2seventy bio, Inc.
General ticker "TSVT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $213.3M (TTM average)
2seventy bio, Inc. does not follow the US Stock Market performance with the rate: -22.5%.
Estimated limits based on current volatility of 0.2%: low 4.99$, high 5.01$
Factors to consider:
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.86$, 5.17$]
- 2025-12-31 to 2026-12-31 estimated range: [2.40$, 5.99$]
Financial Metrics affecting the TSVT estimates:
- Negative: Non-GAAP EPS, $ of -1.59 <= 0.04
- Positive: 43.26 < Shareholder equity ratio, % of 43.96 <= 63.75
- Negative: Operating cash flow per share per price, % of -31.95 <= 1.79
- Negative: negative Net income
- Negative: negative Operating income
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term TSVT quotes
Long-term TSVT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $81.85MM | $100.39MM | $37.86MM |
| Operating Expenses | $344.99MM | $338.00MM | $153.29MM |
| Operating Income | $-263.14MM | $-237.61MM | $-115.43MM |
| Non-Operating Income | $8.99MM | $20.04MM | $58.18MM |
| R&D Expense | $248.74MM | $230.76MM | $76.92MM |
| Income(Loss) | $-254.15MM | $-217.57MM | $-57.25MM |
| Profit(Loss)* | $-254.14MM | $-217.57MM | $-57.25MM |
| Stockholders Equity | $310.47MM | $255.30MM | $210.81MM |
| Inventory | $13.64MM | $0.00MM | $0.00MM |
| Assets | $656.66MM | $565.43MM | $479.51MM |
| Operating Cash Flow | $-228.14MM | $-166.86MM | $-85.00MM |
| Capital expenditure | $22.84MM | $13.87MM | $0.71MM |
| Investing Cash Flow | $3.75MM | $43.86MM | $80.76MM |
| Financing Cash Flow | $166.23MM | $127.39MM | $0.42MM |
| Earnings Per Share** | $-7.13 | $-4.42 | $-1.10 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.